GC021109 for Mild to Moderate Alzheimer's Disease

Language Undefined Purpose: To test the safety and pharmacokinetics of the experimental drug GC021109 in people with mild to moderate Alzheimer's disease. 
Source: Alzheimers Clinical Trials - Category: Geriatrics Authors: Source Type: clinical trials